Logo image of NAD

NUVEEN QUALITY MUNICIPAL INC (NAD) Stock Price, Quote, News and Overview

NYSE:NAD - New York Stock Exchange, Inc. - US67066V1017 - Currency: USD

11.17  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NAD. NAD was compared to 0 industry peers in the Unkown industry. The financial health of NAD is average, but there are quite some concerns on its profitability. NAD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NAD had positive earnings in the past year.
In the past year NAD had a positive cash flow from operations.
NAD had positive earnings in 4 of the past 5 years.
NAD had a positive operating cash flow in each of the past 5 years.
NAD Yearly Net Income VS EBIT VS OCF VS FCFNAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M -600M -800M

1.2 Ratios

Industry RankSector Rank
ROA 0.04%
ROE 0.04%
ROIC 2.02%
ROA(3y)-3.99%
ROA(5y)-0.32%
ROE(3y)-4.3%
ROE(5y)-0.46%
ROIC(3y)2.16%
ROIC(5y)2.15%
NAD Yearly ROA, ROE, ROICNAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

NAD's Profit Margin has declined in the last couple of years.
NAD's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of NAD has declined.
Industry RankSector Rank
OM 58.4%
PM (TTM) 0.95%
GM 58.58%
OM growth 3Y-10.98%
OM growth 5Y-5.49%
PM growth 3Y-26.87%
PM growth 5YN/A
GM growth 3Y-10.95%
GM growth 5Y-5.5%
NAD Yearly Profit, Operating, Gross MarginsNAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, NAD has about the same amount of shares outstanding.
The number of shares outstanding for NAD has been increased compared to 5 years ago.
Compared to 1 year ago, NAD has an improved debt to assets ratio.
NAD Yearly Shares OutstandingNAD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NAD Yearly Total Debt VS Total AssetsNAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

NAD has an Altman-Z score of 12.46. This indicates that NAD is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of NAD is 0.32, which is an excellent value as it means it would take NAD, only 0.32 years of fcf income to pay off all of its debts.
NAD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Although NAD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.32
Altman-Z 12.46
ROIC/WACCN/A
WACCN/A
NAD Yearly LT Debt VS Equity VS FCFNAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 2.73 indicates that NAD has no problem at all paying its short term obligations.
A Quick Ratio of 2.73 indicates that NAD has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73
NAD Yearly Current Assets VS Current LiabilitesNAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

NAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.18%, which is quite impressive.
The earnings per share for NAD have been decreasing by -27.71% on average. This is quite bad
NAD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.63%.
Measured over the past years, NAD shows a small growth in Revenue. The Revenue has been growing by 1.26% on average per year.
EPS 1Y (TTM)105.18%
EPS 3Y-27.71%
EPS 5YN/A
EPS Q2Q%11.67%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y2.4%
Revenue growth 5Y1.26%
Sales Q2Q%1.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAD Yearly Revenue VS EstimatesNAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 58.79, the valuation of NAD can be described as expensive.
NAD is valuated expensively when we compare the Price/Earnings ratio to 26.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 58.79
Fwd PE N/A
NAD Price Earnings VS Forward Price EarningsNAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.17
EV/EBITDA N/A
NAD Per share dataNAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.48%, NAD is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.40, NAD pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.48%

5.2 History

The dividend of NAD decreases each year by -6.94%.
NAD has been paying a dividend for at least 10 years, so it has a reliable track record.
NAD has decreased its dividend recently.
Dividend Growth(5Y)-6.94%
Div Incr Years1
Div Non Decr Years1
NAD Yearly Dividends per shareNAD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

NAD pays out 6638.10% of its income as dividend. This is not a sustainable payout ratio.
DP6638.1%
EPS Next 2YN/A
EPS Next 3YN/A
NAD Yearly Income VS Free CF VS DividendNAD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M -600M -800M
NAD Dividend Payout.NAD Dividend Payout, showing the Payout Ratio.NAD Dividend Payout.PayoutRetained Earnings

More info and screens

NUVEEN QUALITY MUNICIPAL INC

NYSE:NAD (5/29/2025, 8:04:00 PM)

11.17

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)01-03 2025-01-03
Earnings (Next)06-30 2025-06-30
Inst Owners30.4%
Inst Owner Change-9.76%
Ins Owners0.02%
Ins Owner Change0.69%
Market Cap2.61B
Analysts0
Price TargetN/A
Short Float %0.11%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield 7.48%
Yearly Dividend0.49
Dividend Growth(5Y)-6.94%
DP6638.1%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-15 2025-05-15 (0.0755)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 58.79
Fwd PE N/A
P/S 11.78
P/FCF 9.17
P/OCF 9.17
P/B 0.52
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)0.19
EY1.7%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.22
FCFY10.9%
OCF(TTM)1.22
OCFY10.9%
SpS0.95
BVpS21.29
TBVpS21.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.04%
ROE 0.04%
ROCE 2.56%
ROIC 2.02%
ROICexc 2.02%
ROICexgc 2.02%
OM 58.4%
PM (TTM) 0.95%
GM 58.58%
FCFM 128.37%
ROA(3y)-3.99%
ROA(5y)-0.32%
ROE(3y)-4.3%
ROE(5y)-0.46%
ROIC(3y)2.16%
ROIC(5y)2.15%
ROICexc(3y)2.18%
ROICexc(5y)2.17%
ROICexgc(3y)2.18%
ROICexgc(5y)2.17%
ROCE(3y)2.73%
ROCE(5y)2.73%
ROICexcg growth 3Y-5.15%
ROICexcg growth 5Y-3.95%
ROICexc growth 3Y-5.16%
ROICexc growth 5Y-3.95%
OM growth 3Y-10.98%
OM growth 5Y-5.49%
PM growth 3Y-26.87%
PM growth 5YN/A
GM growth 3Y-10.95%
GM growth 5Y-5.5%
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.34
Cash Conversion N/A
Profit Quality 13533.3%
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z 12.46
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.18%
EPS 3Y-27.71%
EPS 5YN/A
EPS Q2Q%11.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.63%
Revenue growth 3Y2.4%
Revenue growth 5Y1.26%
Sales Q2Q%1.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.84%
EBIT growth 3Y-8.84%
EBIT growth 5Y-4.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.66%
FCF growth 3Y8.4%
FCF growth 5YN/A
OCF growth 1Y61.66%
OCF growth 3Y8.4%
OCF growth 5YN/A